although this phenomenon seemed to be related to the IGHV and TP53 status. Our study has also identified relevant mutated genes that may orient the design of specific gene panels for future studies.
A study released by the National Cancer Center Japan has revealed higher rates of mutations in a tumor-suppressing gene, TP53, in Japanese cancer patients compared to those in the United States ...